On Monday, Climb Bio Inc (NASDAQ: CLYM) opened lower -8.59% from the last session, before settling in for the closing price of $1.98. Price fluctuations for CLYM have ranged from $1.05 to $5.47 over the past 52 weeks.
A company in the Healthcare sector has dropped its sales by -40.44% annually for the last half of the decade. Company’s average yearly earnings per share was noted 51.47% at the time writing. With a float of $53.40 million, this company’s outstanding shares have now reached $67.76 million.
Climb Bio Inc (CLYM) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Climb Bio Inc is 21.19%, while institutional ownership is 73.76%. The most recent insider transaction that took place on Jun 30 ’25, was worth 25,154. In this transaction President and CEO of this company sold 20,618 shares at a rate of $1.22, taking the stock ownership to the 48,132 shares. Before that another transaction happened on Jun 20 ’25, when Company’s SVP, Finance & CAO sold 1,242 for $1.24, making the entire transaction worth $1,540. This insider now owns 18,888 shares in total.
Climb Bio Inc (CLYM) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 51.47% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 14.29% during the next five years compared to -40.44% drop over the previous five years of trading.
Climb Bio Inc (NASDAQ: CLYM) Trading Performance Indicators
Check out the current performance indicators for Climb Bio Inc (CLYM). In the past quarter, the stock posted a quick ratio of 14.08.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.69, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach -0.74 in one year’s time.
Technical Analysis of Climb Bio Inc (CLYM)
Let’s dig in a bit further. During the last 5-days, its volume was 0.67 million. That was better than the volume of 0.37 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 10.56%.
During the past 100 days, Climb Bio Inc’s (CLYM) raw stochastic average was set at 47.89%, which indicates a significant increase from 1.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1534 in the past 14 days, which was higher than the 0.1253 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.0383, while its 200-day Moving Average is $1.6063. However, in the short run, Climb Bio Inc’s stock first resistance to watch stands at $1.9790. Second resistance stands at $2.1480. The third major resistance level sits at $2.2375. If the price goes on to break the first support level at $1.7205, it is likely to go to the next support level at $1.6310. The third support level lies at $1.4620 if the price breaches the second support level.
Climb Bio Inc (NASDAQ: CLYM) Key Stats
There are currently 67,764K shares outstanding in the company with a market cap of 122.65 million. Presently, the company’s annual sales total 0 K according to its annual income of -73,900 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -8,670 K.
